View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Swedish Orphan Biovitrum AB: 1 director

A director at Swedish Orphan Biovitrum AB maiden bought 1,900 shares at 405.333SEK and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...

H & M Hennes & Mauritz AB: 1 director

A director at H & M Hennes & Mauritz AB bought 410,335 shares at 181.844SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...

ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke
  • Morten Larsen
ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke
  • Morten Larsen
ABGSC Retail Research ... (+3)
  • ABGSC Retail Research
  • Benjamin Wahlstedt
  • Fredrik Ivarsson
ABGSC Retail Research ... (+3)
  • ABGSC Retail Research
  • Benjamin Wahlstedt
  • Fredrik Ivarsson
ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke
  • Morten Larsen
ABGSC Retail Research ... (+4)
  • ABGSC Retail Research
  • Alice Beer
  • Benjamin Wahlstedt
  • Fredrik Ivarsson
ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke
  • Morten Larsen
 PRESS RELEASE

Data presented at ACR Convergence 2025 highlight Sobi’s commitment to ...

Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions NASP data highlight reduction in disease burden among people living with uncontrolled gout Gamifant (emapalumab) data showed response rates in patients with MAS in Still’s disease across MAS subtypes, including in those with recurrent disease Discussion of the first ever international, randomized, multicentre, double-blind, placebo-controlled phase 2 dose finding trial of Vonjo® (pacritinib) in adult patients with VEXAS syndrome WALTHAM, Mass., Oct. 25...

ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke
  • Morten Larsen
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch